Alison M. McCaig

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study

Peter Hillmen, Andy C. Rawstron, Kristian Brock et al. · Journal of Clinical Oncology · 2019 · 264 citations · Full text

Neuregulin expression, function, and signaling in human ovarian cancer cells.

L Gilmour, Kenneth G. MacLeod, Alison M. McCaig et al. · PubMed · 2002 · 83 citations

Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro‐survival microenvironmental signals

Alison M. McCaig, Emilio Cosimo, Michael T. Leach et al. · British Journal of Haematology · 2011 · 81 citations · Full text

Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL

Odette Middleton, Emilio Cosimo, Edwina Dobbin et al. · Leukemia · 2014 · 77 citations

Complement System, Allergy, Autoimmune Disease +10

Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer.

L Gilmour, K G Macleod, Alison M. McCaig et al. · PubMed · 2001 · 73 citations

Oncology, Erbb4 Protein, Medicine +12